Evidence map›Paper›PMID 36869088›Full record

ArticleCommunications biology2023

Effect of Fc core fucosylation and light chain isotype on IgG1 flexibility.

Simona Saporiti, Tommaso Laurenzi, Uliano Guerrini, Crescenzo Coppa, Wolf Palinsky, Giulia Benigno, Luca Palazzolo, Omar Ben Mariem, Linda Montavoci, Mara Rossi and 2 more

Abstract read
In one paragraph

Article in Communications biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Refined Protein-Sugar Interactions in the Martini Force Field.Journal of chemical theory and computation · 2024
    Article
  8. Frontiers in immunology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Simona SaporitiDipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Via Balzaretti, 9, 20133, Milan, Italy.ORCID 0000-0002-2096-1066
Tommaso LaurenziDipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Via Balzaretti, 9, 20133, Milan, Italy.ORCID 0000-0002-0446-0392
Uliano GuerriniDipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Via Balzaretti, 9, 20133, Milan, Italy.
Crescenzo CoppaDipartimento di Scienze Farmaceutiche, Università degli Studi di Milano, Sezione di Chimica Generale e Organica "A. Marchesini", Via Venezian, 21, 20133, Milano, Italy.ORCID 0000-0003-0574-9187
Wolf PalinskyBiotech Development Programme, Merck Biopharma, Aubonne, Switzerland.ORCID 0000-0002-2779-7510
Giulia BenignoDipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Via Balzaretti, 9, 20133, Milan, Italy.
Luca PalazzoloDipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Via Balzaretti, 9, 20133, Milan, Italy.ORCID 0000-0002-5370-9588
Omar Ben MariemDipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Via Balzaretti, 9, 20133, Milan, Italy.
Linda MontavociDipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Via Balzaretti, 9, 20133, Milan, Italy.
Mara RossiGlobal Analytical Pharmaceutical Science and Innovation, Merck Serono S.p.A., Rome, Italy.
Fabio Centola *Global Analytical Pharmaceutical Science and Innovation, Merck Serono S.p.A., Rome, Italy. fabio.centola@merckgroup.com.
Ivano Eberini *Dipartimento di Scienze Farmacologiche e Biomolecolari & DSRC, Università degli Studi di Milano, Via Balzaretti, 9, 20133, Milan, Italy.

Funding

Ministero dell'Istruzione, dell'Università e della Ricerca (Ministry of Education, University and Research) 2018–2022
6 · The paper itself

Abstract

N-glycosylation plays a key role in modulating the bioactivity of monoclonal antibodies (mAbs), as well as the light chain (LC) isotype can influence their physicochemical properties. However, investigating the impact of such features on mAbs conformational behavior is a big challenge, due to the very high flexibility of these biomolecules. In this work we investigate, by accelerated molecular dynamics (aMD), the conformational behavior of two commercial immunoglobulins G1 (IgG1), representative of κ and λ LCs antibodies, in both their fucosylated and afucosylated forms. Our results show, through the identification of a stable conformation, how the combination of fucosylation and LC isotype modulates the hinge behavior, the Fc conformation and the position of the glycan chains, all factors potentially affecting the binding to the FcγRs. This work also represents a technological enhancement in the conformational exploration of mAbs, making aMD a suitable approach to clarify experimental results.

Indexed as

Antibodies, MonoclonalImmunoglobulin GGlycosylationTechnologyAntibodies, MonoclonalImmunoglobulin G

Identifiers

PMID36869088
PMCPMC9982779

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.